These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 8411503)
1. Immunoaugmentative therapy. An unproven cancer treatment. Green S JAMA; 1993 Oct; 270(14):1719-23. PubMed ID: 8411503 [TBL] [Abstract][Full Text] [Related]
2. Clinical evaluation of "immunoaugmentative therapy (IAT)": an unconventional cancer treatment. Pfeifer BL; Jonas WB Integr Cancer Ther; 2003 Jun; 2(2):112-9. PubMed ID: 15035898 [TBL] [Abstract][Full Text] [Related]
3. Questionable methods of cancer management. Immuno-augmentative therapy (IAT). CA Cancer J Clin; 1991; 41(6):357-64. PubMed ID: 1933535 [TBL] [Abstract][Full Text] [Related]
4. From the History of the Croatian Dermatovenereological Society - The Croatian Medical Association and an Overview of Important Information Regarding the Journal Acta Dermatovenerologica Croatica. Dobrić I Acta Dermatovenerol Croat; 2018 Dec; 26(4):344-348. PubMed ID: 30665489 [TBL] [Abstract][Full Text] [Related]
5. Abass Alavi: A giant in Nuclear Medicine turns 80 and is still going strong! Høilund-Carlsen PF Hell J Nucl Med; 2018; 21(1):85-87. PubMed ID: 29550853 [TBL] [Abstract][Full Text] [Related]
7. Immunoaugmentative therapy. A primer on the perils of unproved treatments. Curt GA; Katterhagen G; Mahaney FX JAMA; 1986 Jan 24-31; 255(4):505-7. PubMed ID: 3001379 [TBL] [Abstract][Full Text] [Related]
10. "Just Another Statistic". Machtay M; Glatstein E Oncologist; 1998; 3(3):III-IV. PubMed ID: 10388105 [TBL] [Abstract][Full Text] [Related]
11. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies. Bodey B; Siegel SE; Kaiser HE Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112 [TBL] [Abstract][Full Text] [Related]
12. Cancer vaccines: an update with special focus on ganglioside antigens. Bitton RJ; Guthmann MD; Gabri MR; Carnero AJ; Alonso DF; Fainboim L; Gomez DE Oncol Rep; 2002; 9(2):267-76. PubMed ID: 11836591 [TBL] [Abstract][Full Text] [Related]
13. The critical role of type-1 innate and acquired immunity in tumor immunotherapy. Ikeda H; Chamoto K; Tsuji T; Suzuki Y; Wakita D; Takeshima T; Nishimura T Cancer Sci; 2004 Sep; 95(9):697-703. PubMed ID: 15471553 [TBL] [Abstract][Full Text] [Related]
14. The concept of immune surveillance against tumors. The first theories. Ribatti D Oncotarget; 2017 Jan; 8(4):7175-7180. PubMed ID: 27764780 [TBL] [Abstract][Full Text] [Related]
15. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1. Lunsford LD; Flickinger JC; Larson D Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030 [TBL] [Abstract][Full Text] [Related]
16. Unproven (questionable) dietary and nutritional methods in cancer prevention and treatment. Herbert V Cancer; 1986 Oct; 58(8 Suppl):1930-41. PubMed ID: 3756812 [TBL] [Abstract][Full Text] [Related]
17. Democritus Junior as Reader of Auctoritates: Robert Burton's Method and The Anatomy of Melancholy. Mori G J Hist Ideas; 2016 Jul; 77(3):379-99. PubMed ID: 27477342 [TBL] [Abstract][Full Text] [Related]
19. Overview of resistance to systemic therapy in patients with breast cancer. Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229 [TBL] [Abstract][Full Text] [Related]
20. A global approach to tumor immunology. Wang E; Panelli MC; Monsurró V; Marincola FM Cell Mol Immunol; 2004 Aug; 1(4):256-65. PubMed ID: 16225768 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]